News

Aubry Daerden Enriches Crowell & Moring's Team in Brussels

Aubry Daerden Enriches Crowell & Moring's Team in Brussels

Aubry Daerden Enhances Crowell & Moring's Brussels Office

Strengthens cross-border transactional capabilities

BRUSSELS / -- Aubry Daerden has joined Crowell & Moring's Brussels office as a partner in the Corporate Group, expanding the firm's capability to represent clients on complex corporate transactions in Belgium and the EU.

Daerden brings a proven track record of managing both cross-border and domestic deals, including strategic mergers and acquisitions, private equity transactions, and joint ventures across various sectors such as life sciences, healthcare, transportation, and infrastructure. His expertise extends to aiding emerging technology companies, venture capital firms, and corporate investors throughout all stages of investment.

According to Thomas De Meese, co-managing partner of the firm's Brussels office, "Aubry's addition to our team enhances our ability to serve clients navigating sophisticated corporate matters. His deep transactional experience and commercial mindset will provide significant value to our clients and further our commitment to excellence in client service."

John Koenigsknecht, chair of Crowell's Corporate Group, expressed, "We are delighted to welcome Aubry to our corporate team. With over a decade of experience in mergers and acquisitions and private equity, he brings valuable insights and skills to our practice. He has advised clients globally across many industries, including life sciences transactions, which is a key area where we have recently expanded our capabilities. His arrival supports our strategic goal of enhancing our corporate transactional capabilities in Brussels and London, broadening our reach in key European markets."

With a background that includes pivotal roles in landmark Belgian transactions over the past decade, Daerden is also known for supporting clients making investments in Luxembourg. Leveraging his in-depth knowledge of the French market, he has been instrumental in numerous high-profile Belgian-French cross-border deals, working frequently with CAC 40 companies and private equity sponsors in France concerning their interests in the Benelux region. Alongside his transactional practice, he serves as a trusted advisor to family shareholders, private companies, and trade associations on governance, compliance, and various corporate law matters.

Reflecting on his new role, Daerden stated, "I am honored to join Crowell, a high-caliber law firm with some of the brightest legal minds in Brussels and internationally. The firm has successfully maintained its agility and integration while expanding globally. At Crowell, I immediately felt a genuine sense of community and a culture of excellence, united by a shared vision to serve clients with the utmost standards, all while keeping a sense of humor. I look forward to assisting the firm's ongoing ambitions to expand its corporate capabilities in Europe and beyond while collaborating with clients on their strategic projects."

Daerden holds a bachelor’s degree in law and a master’s degree in private law from the Free University of Brussels, coupled with a LL.M. in international economic law from the Chinese University of Hong Kong.

Since 2023, he has been consistently recognized as a "Rising Star" in corporate law, mergers, acquisitions, and commercial matters by a leading legal publication.

About Crowell & Moring LLP

Crowell & Moring LLP is an international law firm with operations in the United States, Europe, MENA, and Asia. Leveraging extensive government, business, industry, and legal experience, the firm empowers clients to seize opportunities while providing innovative solutions for complex regulatory and policy, litigation, transactional, and intellectual property challenges. The firm is widely acknowledged for its commitment to pro bono service and its comprehensive initiatives promoting the professional and personal development of all members of the Crowell community.

Media Contact

Email: [contact email]

Frequently Asked Questions

What is the significance of Aubry Daerden joining Crowell & Moring?

Aubry Daerden's addition enhances Crowell & Moring's capabilities in handling complex corporate transactions, benefitting their clients significantly.

What is the background of Aubry Daerden?

Aubry Daerden has over a decade of experience in mergers and acquisitions and specializes in various sectors, including life sciences and healthcare.

What are Crowell & Moring's key practice areas?

The firm focuses on regulatory and policy challenges, litigation, transactional law, intellectual property, and corporate matters.

How does Crowell & Moring support professional development?

Crowell & Moring is recognized for its commitment to pro bono service and offers comprehensive programs aimed at enhancing professional growth.

What kind of clients does Aubry Daerden typically work with?

He frequently assists emerging technology companies, venture capital firms, and corporate investors, addressing their diverse investment needs.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 14

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading

Top 5 Most Recently Viewed Articles

CeraVe Marks 20 Years of Groundbreaking Skincare Innovations

Updated Category News Views 259

CeraVe's Celebrated Journey in Skincare CeraVe is making waves as it marks an impressive milestone: 20 years of dedicated skincare science. Launching with the mission to nurture and restore skin health, the brand has garnered an extensive following of both customers and dermatology professionals worldwide. By focusing on skin barrier health and utilizing innovative...

Continue Reading
Exploring Novartis' Latest Innovations in Hematology and Oncology

Updated Category News Views 320

Novartis Pioneers Innovations in Hematology and Oncology Basel – Novartis has been making headlines with groundbreaking data presented at major medical meetings, including the esteemed American Society of Hematology (ASH) Annual Meeting and the San Antonio Breast Cancer Symposium (SABCS). This year, Novartis is showcasing over 70 abstracts with significant findings that...

Continue Reading
Sustainable Green Team Reveals Patents for Eco-Innovation

Updated Category News Views 189

Innovative Patents by Sustainable Green Team Sustainable Green Team, Ltd. (OTC: SGTM) is making significant strides in environmental responsibility by filing an impressive portfolio of 20 U.S. provisional patent applications. This initiative marks the unveiling of the SGTM 20-Patent Fortress™, consolidating the company's dedication to revolutionizing waste management...

Continue Reading
SSL's C2PA Game Changer: Authenticity or Just Hype?

Updated Category News Views 172

SSL just dropped a bombshell on the digital content authenticity scene. On February 18, 2026, they announced themselves as the first publicly trusted certificate authority to roll out production-ready C2PA-conformant certificates. But what’s behind all this noise? Desks are buzzing about whether this marks a real breakthrough against deepfakes and misinformation or if...

Continue Reading
MiMedia's Innovations at Mobile World Congress Excite Investors

Updated Category News Views 95

MiMedia Partners with Orbic at Mobile World Congress MiMedia Holdings Ltd. is excited to announce its collaboration with Orbic, a prominent US OEM, to develop and market the new line of rugged devices under the Caterpillar brand. This partnership was highlighted during the recently attended Mobile World Congress conference, where innovative trends within the tech industry...

Continue Reading